We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the ...

Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

Hawaiʻi secures a $700 million settlement with pharmaceutical companies BMS and Sanofi, ending a 12-year lawsuit, with funds ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide list price for new medicines is "deeply flawed" and would not solve ...